These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 5147878
1. [Rhythmic activity of the adrenal cortex in hypertension and Itsenko-Cushing disease]. Pomoshchnikova NI. Kardiologiia; 1971; 11(12):119-20. PubMed ID: 5147878 [No Abstract] [Full Text] [Related]
2. [Steroid biosynthesis in the adrenals in Itsenko-Cushing syndrome]. Iudaev NA, Razina LG, Morozova MS, Kertsman VI, Marova EI. Probl Endokrinol (Mosk); 1971; 17(6):3-11. PubMed ID: 5148145 [No Abstract] [Full Text] [Related]
3. [Electrolyte metabolism and the condition of glucocorticoid and mineralocorticoid functions of the adrenal cortex in different forms of Itsenko-Cushing's syndrome]. Vasiukova EA, Granovskaia AM, Kasatkin IuN, Ryzhikov VD, Avramenko MM. Klin Med (Mosk); 1975 Mar; 53(3):109-12. PubMed ID: 1117666 [No Abstract] [Full Text] [Related]
5. Cytochrome P450 and steroid 11beta-hydroxylation in mitochondria from human adrenal cortex. Wilson LD, Oldham SB, Harding BW. J Clin Endocrinol Metab; 1968 Aug; 28(8):1143-52. PubMed ID: 4386376 [No Abstract] [Full Text] [Related]
6. [A comparative evaluation of the functional state of the adrenal cortex in puberty-juvenile dyspituitarism and Itsenko-Cushing disease (second report)]. Egart FM, Lemesheva SN, Goncharova VN. Probl Endokrinol (Mosk); 1973 Aug; 19(4):37-40. PubMed ID: 4788098 [No Abstract] [Full Text] [Related]
7. Failure of metyrapone to inhibit 11-hydroxylation of 11-deoxycortisol during drug therapy. Werk EE, Thrasher K, Choi Y, Sholiton LJ. J Clin Endocrinol Metab; 1967 Sep; 27(9):1358-60. PubMed ID: 4292251 [No Abstract] [Full Text] [Related]
8. [Use of elipten in Itsenko-Cushing disease (preliminary report)]. Marova EI, Lemesheva SN. Probl Endokrinol (Mosk); 1970 Sep; 16(5):7-10. PubMed ID: 5520275 [No Abstract] [Full Text] [Related]
9. Testing in hypertension. Mendlowitz M, Naftchi NE, Gitlow SE, Wolf RL. Isr J Med Sci; 1969 Sep; 5(4):605-7. PubMed ID: 5820485 [No Abstract] [Full Text] [Related]
13. Considerations in diagnosis of Cushing syndrome. Khardori R, Abraham M. Arch Intern Med; 2001 Jul 23; 161(14):1780. PubMed ID: 11485515 [No Abstract] [Full Text] [Related]
14. [Clinical characteristics of Itsenko-Cushing syndrome with various morphological changes in the adrenal cortex]. Baranov VG, Nechaĭ AI, Trofimov VM, Savushkina AS, Kalashnikov SA. Probl Endokrinol (Mosk); 1986 Jul 23; 32(3):30-4. PubMed ID: 3016700 [Abstract] [Full Text] [Related]
15. [Some problems of the differential diagnosis of changes in the adrenal glands in Itsenko-Cushing disease and metabolic tumors of the adrenal cortex]. Bukhman AI, Kalinin AP, Kertsman VI. Vestn Khir Im I I Grek; 1966 Oct 23; 97(10):32-6. PubMed ID: 6001773 [No Abstract] [Full Text] [Related]
16. [Clinical and biohormonal picture of Cushing-like syndrome in girls]. Krawczuk A. Ginekol Pol; 1965 Oct 23; 36(10):1165-72. PubMed ID: 5854817 [No Abstract] [Full Text] [Related]
18. [Lipolysis in fatty tissue of patients with adrenohypercorticism]. Tishenina RS. Vopr Med Khim; 1983 Oct 23; 29(6):15-20. PubMed ID: 6322439 [Abstract] [Full Text] [Related]